Should women with node-negative breast cancer receive adjuvant chemotherapy? — Insights from a decision analysis model Bruce E. HillnerThomas J. Smith 14th Annual San Antonio Breast Cancer Symposium — Plenary Lecture Pages: 17 - 27
Contraceptive steroids and the mammary gland: Is there a hazard? GR Rutteman Viewpoint Pages: 29 - 41
Proliferative activity of breast cancers increases in the course of genetic evolution as defined by cytogenetic analysis Y. RemvikosM. Gerbault-SeureauB. Dutrillaux Report Pages: 43 - 49
Breast tumor-derived factors stimulate reduction of estrone to estradiol in nonmalignant breast tissue Rajeshwari R. MehtaJewell M. Graves Report Pages: 51 - 56
Influence of aminoglutethimide on plasma oestrogen levels in breast cancer patients on 4-hydroxyandrostenedione treatment P. E. LønningM. DowsettT. J. Powles Report Pages: 57 - 62
Cytosol cathepsin-D content and proliferative activity of human breast cancer Angelo ParadisoAnita MangiaAngela Riccobon Report Pages: 63 - 70
Immunohistochemical reaction to human milk fat globule antibodies and breast cancer differentiation Ernest E. SternsWilliam A. FletcherBennie Zee Report Pages: 71 - 76
Secretion of breast gross cystic disease fluid proteins by T47D breast cancer cells in culture — modulation by steroid hormones Darrow E. HaagensenPeter StewartSamuel A. Wells Report Pages: 77 - 86
Characterization of two human mammary carcinomas, MT-1 and MT-3, suitable forin vivo testing of ether lipids and their derivatives H. NaundorfE. C. RewasowaM. Görlich Report Pages: 87 - 95
Control of proliferation of MCF-7 breast cancer cells in a commercial preparation of charcoal-stripped adult bovine serum Wade V. WelshonsLeigh H. GradyBarbara M. Judy Report Pages: 97 - 104
15th Annual San Antonio Breast Cancer Symposium presents Fifth Annual Antonio Flow Cytometry Forum December 7–8, 1992 Events Pages: 107 - 130
